Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of DermGEN Dermal Regeneration Scaffold for the Treatment of Diabetic Foot Ulcers

NCT02184455 is registered in ClinicalTrials.gov with Dr. Paul F. Gratzer as lead sponsor.

NCT NCT02184455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02184455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of DermGEN Dermal Regeneration Scaffold for the Treatment of Diabetic Foot Ulcers
Lead sponsor
Dr. Paul F. Gratzer
Phase
Phase 1
Overall status
Completed
Start date
July 1, 2016
Completion date
May 1, 2017
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type i, diabetes type ii